Medpace (MEDP) CEO sells 4,673 shares near $620 in open-market trades
Rhea-AI Filing Summary
Medpace Holdings, Inc. (MEDP) reported that President & CEO August J. Troendle sold common stock in two open-market transactions. On August 26, 2026, he sold 4,000 shares at a weighted average price of $620.03 per share, in multiple trades between $620.00 and $620.54. On August 25, 2026, he sold 673 shares at a weighted average price of $620.38 per share, in multiple trades between $620.00 and $621.89. The sales were effected pursuant to a limit order placed during an open window period. The filing also notes indirect ownership of 4,733,019 shares held by Medpace Investors, LLC, over which Troendle has sole voting and investment control, while he disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 4,673 shares
Net Sell
3 txns
Insider
Troendle August J.
Role
President & CEO
Sold
4,673 shs ($2.90M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F3 | 4,000 | $620.03 | $2.48M |
| Sale | Common Stock F1, F2 | 673 | $620.38 | $418K |
| holding | Common Stock F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 540,544 shares (Direct);
Common Stock — 4,733,019 shares (Indirect, By Medpace Investors, LLC)
Footnotes (4)
- F1. The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- F2. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $621.89. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F3. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $620.54. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- F4. The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Key Figures
Shares sold on 2026-08-26: 4,000 shares of Common Stock
Weighted average sale price on 2026-08-26: $620.03 per share
Shares sold on 2026-08-25: 673 shares of Common Stock
+3 more
6 metrics
Shares sold on 2026-08-26
4,000 shares of Common Stock
Open-market sale by August J. Troendle on August 26, 2026
Weighted average sale price on 2026-08-26
$620.03 per share
Common Stock sold in multiple transactions between $620.00 and $620.54
Shares sold on 2026-08-25
673 shares of Common Stock
Open-market sale by August J. Troendle on August 25, 2026
Weighted average sale price on 2026-08-25
$620.38 per share
Common Stock sold in multiple transactions between $620.00 and $621.89
Total shares sold in reported transactions
4,673 shares of Common Stock
Sum of the two sale transactions reported in this Form 4
Indirectly held shares via Medpace Investors, LLC
4,733,019 shares of Common Stock
Indirect holdings with sole voting and investment control, subject to pecuniary-interest disclaimer
Key Terms
limit order, open window period, weighted average price, indirectly beneficially own, +1 more
5 terms
limit order financial
"transactions reported on this Form 4 were effected pursuant to a limit order"
A limit order is an instruction to buy or sell a stock only at a specific price or better, giving you control over the exact price you pay or receive. It matters to investors because it acts like a price guard—similar to setting a maximum you’ll pay for an item at a store—so you avoid unexpected prices, though the trade may not happen if the market never reaches your limit.
open window period regulatory
"limit order placed by the Reporting Person during an open window period"
weighted average price financial
"The reported price is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
indirectly beneficially own regulatory
"may be deemed to indirectly beneficially own the securities of the Issuer"
pecuniary interest financial
"disclaims beneficial ownership of such securities except to the extent of his pecuniary interest"
FAQ
What insider transactions did MEDP CEO August J. Troendle report in this Form 4?
August J. Troendle reported selling 4,673 Medpace Holdings, Inc. (MEDP) common shares in two open-market transactions on August 25–26, 2026, at weighted average prices of $620.38 and $620.03 per share, executed under a limit order during an open window period.
Were the recent MEDP insider sales done under a trading or limit order?
The filing states the MEDP insider sales were effected pursuant to a limit order placed by August J. Troendle during an open window period; it does not describe them as made under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
